Related Experiment Video
Updated: Aug 6, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
[In vitro resistance of Candida species to antifungal agents]
W Banach-Piatkowska1, A Kotłowski, J Humanowska
1Zakład Medycyny Tropikalnej Instytutu Medycyny Morskiej i Tropikalnej w Gdyni 81-519 Gdynia, ul. Powstania Styczniowego 9b.
Abstract:
The purpose of this study was to determine the in vitro susceptibility to 6 antifungal agents of 143 strains of Candida species isolated from 545 patients with suspicion of fungal infection. Test ATB Fungus (bioMérieux) was used. Among all Candida isolates 91.6% were susceptible to tested polyenes and 32.9% to all azoles. Less susceptible to polyenes isolates were noted in low percentage (0.7 to 4.2%) and to azoles more frequently (32.9 to 41.2%). Candida isolates resistant to antifungal agents tested were dependent from the kind of clinical samples and species of fungi. Monitoring of the susceptibility to antifungal agents by ATB commercial test seems to be useful tool for therapeutic purposes.
Insights
Most Candida species showed susceptibility to polyenes (91.6%) but fewer to azoles (32.9%). Antifungal resistance varied by fungal species and sample type, highlighting the need for susceptibility monitoring.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Fungal infections caused by Candida species are a significant global health concern.
- Antifungal resistance is an emerging challenge in treating these infections.
- Understanding the susceptibility patterns of Candida isolates is crucial for effective treatment strategies.
Purpose of the Study:
- To evaluate the in vitro susceptibility of clinical Candida isolates to six antifungal agents.
- To determine the prevalence of resistance to polyenes and azoles among these isolates.
- To explore the relationship between antifungal susceptibility, fungal species, and clinical sample source.
Main Methods:
- Analysis of 143 Candida strains isolated from 545 patients suspected of fungal infections.
- In vitro susceptibility testing using the ATB Fungus (bioMérieux) commercial assay.
- Categorization of susceptibility based on resistance to polyenes and azoles.
Main Results:
- High susceptibility (91.6%) was observed for polyenes, while lower susceptibility (32.9%) was noted for azoles against all Candida isolates.
- Low percentages of resistance were found for polyenes (0.7% to 4.2%), contrasting with higher rates for azoles (32.9% to 41.2%).
- Antifungal resistance patterns were found to be dependent on the clinical sample source and the specific Candida species.
Conclusions:
- The study demonstrates significant variations in Candida susceptibility to different antifungal classes.
- The ATB Fungus test is a valuable tool for monitoring antifungal susceptibility in clinical settings.
- Tailoring antifungal therapy based on susceptibility data is essential for optimizing patient outcomes.
More Related Videos
Related Concept Videos
Candidiasis
Antifungal Agents
Antimicrobial Effectiveness

